Clasado Biosciences, a global leader in the development of scientifically proven prebiotic ingredients and product solutions for the gut microbiome, has appointed Prokopton SAS as its distribution partner in France, strengthening its presence in one of Europe’s most significant prebiotics markets.
Under the agreement, Éguilles-based Prokopton will supply Bimuno GOS to brands and manufacturers across the French supplements, food and beverage, and pet nutrition sectors.
France presents a clear and growing commercial opportunity. The French prebiotics market is projected to reach USD 387.91 million by 2032, at a CAGR of 7.26%.
Consumer engagement is strong and, critically, extends beyond reactive health management. According to FMCG Gurus data, 51% of French consumers are interested in digestive health products even when not experiencing specific health concerns, and prebiotics awareness stands at 55%, with 42% of those consumers having purchased a product with prebiotic benefits in the past twelve months.
Annika Malmros, Director of Business Development at Clasado, commented: “France is an appealing European market for prebiotics, and this appointment reflects our commitment to ensuring that brands and manufacturers across the region have straightforward access to Bimuno GOS. Prokopton has a well-established position across supplements, food and beverage, and pet nutrition sectors, combined with a deep understanding of the French market. As such, it’s exactly the right partner to support brands looking to meet growing consumer demand with a prebiotic ingredient they can stand behind.”
Yazan El Safadi, Managing Director at Prokopton, added: “French consumers are ahead of the curve. They’re not waiting to feel unwell before they act, they’re making considered choices about their health every day, and gut health is firmly on their radar, they are well aware of how foundational gut health is to their wellbeing and lifespan. That’s exactly the kind of consumer environment where Bimuno GOS thrives: a market that’s ready for an ingredient with real science behind it, not just a trend label. We rarely come across ingredients with such a solid scientific backing, and Bimuno GOS earns its place.”
Bimuno GOS is the most widely studied prebiotic of its kind, backed by more than 130 scientific publications and over 25 clinical trials. It works by selectively feeding beneficial bacteria in the gut microbiome, including Bifidobacteria, bacteria closely associated with gastrointestinal, immune and cognitive wellbeing. Its versatility across product formats makes it well suited to the diverse formulation needs of the French market.
For further information on Clasado Biosciences and the science behind Bimuno GOS, please visit www.clasado.com.
